Sanj K. Patel - Nov 12, 2025 Form 4 Insider Report for Kiniksa Pharmaceuticals International, plc (KNSA)

Role
CHAIRMAN & CEO, Director
Signature
/s/ Douglas Barry, Attorney-in-Fact
Stock symbol
KNSA
Transactions as of
Nov 12, 2025
Transactions value $
$0
Form type
4
Date filed
11/14/2025, 04:38 PM
Previous filing
Oct 22, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Patel Sanj K CHAIRMAN & CEO, Director 105 PICCADILLY, SECOND FLOOR, LONDON, UNITED KINGDOM /s/ Douglas Barry, Attorney-in-Fact 2025-11-14 0001532218

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KNSA Class A Ordinary Share Gift $0 -112K -100% $0.00 0 Nov 12, 2025 Direct
transaction KNSA Class A Ordinary Share Gift $0 +112K $0.00 112K Nov 12, 2025 Held by The Anglia 2013 Revocable Trust
transaction KNSA Class A Ordinary Share Gift $0 -60K -53.67% $0.00 51.8K Nov 13, 2025 Held by The Anglia 2013 Revocable Trust
transaction KNSA Class A Ordinary Share Gift $0 +60K $0.00 60K Nov 13, 2025 Held by The Patel Family Irrevocable Trust of 2025
holding KNSA Class A Ordinary Share 110K Nov 12, 2025 Held by The Marina 2016 Irrevocable Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.